Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone – a case report

2004 ◽  
Vol 5 (4) ◽  
pp. 361-363 ◽  
Author(s):  
Stefan Wöhrer ◽  
Jutta Ackermann ◽  
Catrin Baldia ◽  
Sonja Seidl ◽  
Markus Raderer ◽  
...  
Keyword(s):  
Case Report ◽  
Effective Treatment ◽  
Plasma Cell ◽  
Plasma Cell Leukemia ◽  
Cell Leukemia ◽  
Primary Plasma Cell Leukemia

scholarly journals Primary Plasma cell Leukemia- a Case Report

2020 ◽  
Vol 5 (12) ◽  
pp. 501-503
Author(s):  
  Dr. Aswathy Shibu ◽  
Dr. Jayalakshmy P L ◽  
Dr. Sankar S
Keyword(s):  
Case Report ◽  
Plasma Cell ◽  
Plasma Cell Leukemia ◽  
Cell Leukemia ◽  
Primary Plasma Cell Leukemia

A RARE CASE PRESENTATION OF PRIMARY PLASMA CELL LEUKEMIA WITH REVIEW OF LITERATURE, A CASE REPORT

2021 ◽  
pp. 21-22
Author(s):  
Gaurav Sharma ◽  
Smita Sharma
Keyword(s):  
Case Report ◽  
Plasma Cell ◽  
Peripheral Blood ◽  
Plasma Cells ◽  
Plasma Cell Leukemia ◽  
Rare Entity ◽  
Cell Leukemia ◽  
Case Presentation ◽  
Blood Examination ◽  
Primary Plasma Cell Leukemia

Introduction: Primary Plasma Cell Leukemia (pPCL) is Plasma cell dyscrasia subtype which is rare and aggressive. It carries very poor prognosis. It has unique clinical and laboratory prole. Its rst clinical presentation is leukemia. Peripheral blood examination shows circulating mature looking yet clonal, plasma cells. On molecular and cytogenetic examinations, many aberrations are seen which are unique and make it a distinct entity different from traditional Multiple Myeloma (MM). Case presentation: 37 yr old Indian female presented with difculty in breathing for last 3 months and was initially evaluated for cardiac function & COVID-19 screening. Peripheral blood examination revealed circulating plasma cells. Bone marrow apirate conrmed the initial diagnosis of pPCL. She received BIODRONATE + Inj. BORTEZOMIB + Inj. CYCLOPHOSPHAMIDE + Tab Dexa and was advised for PETscan and skeletal survey. But due to nancial constraints, family decided to go for complete systemic workup in next phase of chemotherapy cycle. She was discharged with advise to be in close follow up and to complete her treatment cycles. Discussion: pPCL needs to be diagnosed promptly to formulate optimal intensive therapy. This atypical presentation with shortness of breath of rare entity of pPCLin such young age emphasizes the need for quick and thorough initial workup. Conclusion: Because of rarity of this disease, there is paucity of literature from India and especially the impact of the standard therapies in resource poor countries. Our case report highlights these challenges for conclusive management of this rare entity

Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: A case report

2009 ◽  
Vol 33 (11) ◽  
pp. e191-e193 ◽  
Author(s):  
Attilio Olivieri ◽  
Immacolata Attolico ◽  
Michele Cimminiello ◽  
Giancarlo Discepoli ◽  
Rosa Anna Cifarelli
Keyword(s):  
Case Report ◽  
Plasma Cell ◽  
Plasma Cell Leukemia ◽  
Cell Leukemia ◽  
Graft Versus Leukemia ◽  
Primary Plasma Cell Leukemia ◽  
Graft Versus Leukemia Effect

scholarly journals PRIMARY PLASMA CELL LEUKEMIA: A RARE CASE REPORT

2019 ◽  
Vol 05 (06) ◽  
pp. 569-570
Author(s):  
Manmeet Kaur ◽  
Kanwardeep Kaur ◽  
Amandeep Kaur
Keyword(s):  
Case Report ◽  
Plasma Cell ◽  
Rare Case ◽  
Plasma Cell Leukemia ◽  
Cell Leukemia ◽  
Rare Case Report ◽  
Primary Plasma Cell Leukemia

Increased Serum Tumor Markers (CA125 and CA15.3) in Primary Plasma Cell Leukemia: A Case Report and Review of the Literature

2008 ◽  
Vol 8 (5) ◽  
pp. 312-314 ◽  
Author(s):  
Carlos Fernández de Larrea ◽  
Maria Teresa Cibeira ◽  
Rolando Vallansot ◽  
Lluís Colomo ◽  
Joan Bladé
Keyword(s):  
Case Report ◽  
Tumor Markers ◽  
Plasma Cell ◽  
Plasma Cell Leukemia ◽  
Review Of The Literature ◽  
Cell Leukemia ◽  
Serum Tumor Markers ◽  
Primary Plasma Cell Leukemia
Sign in / Sign up

Export Citation Format

Share Document